With analysis of targeted expression of CCDC102B in breast cancer patients with different nodal status, we found significantly higher expression of CCDC102B in LN-positive patients (P=0.0005, Supplementary Figure 2B). This evidence concerns the gene CCDC102B and breast carcinoma.